{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:16:26Z","timestamp":1788430586591,"version":"build-2803163510"},"reference-count":127,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology","doi-asserted-by":"publisher","award":["BT\/RLF\/Re-entry\/38\/2017"],"award-info":[{"award-number":["BT\/RLF\/Re-entry\/38\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.arcmed.2025.103366","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:46:02Z","timestamp":1767609962000},"page":"103366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding the Mutational Hierarchy of Thyroid Cancer and Associated Signaling Pathways"],"prefix":"10.1016","volume":"57","author":[{"given":"Disha","family":"Nashier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3821-9319","authenticated-orcid":false,"given":"Gowrang Kasaba","family":"Manjunath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumira","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamoghna","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muniasamy","family":"Neerathilingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4172-4059","authenticated-orcid":false,"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2025.103366_bib0001","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nrendo.2011.142","article-title":"Molecular genetics and diagnosis of thyroid cancer","volume":"7","author":"Nikiforov","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0002","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/ijc.31884","article-title":"Thyroid cancer \u201cepidemic\u201d also occurs in low-and middle-income countries","volume":"144","author":"Lortet-Tieulent","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0003","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1158\/1055-9965.EPI-21-1440","article-title":"Epidemiology of Thyroid Cancer","volume":"31","author":"Kitahara","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.arcmed.2025.103366_bib0004","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S2213-8587(20)30115-7","article-title":"Global trends in thyroid cancer incidence and the impact of overdiagnosis","volume":"8","author":"Li","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0005","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2217\/fon.10.127","article-title":"Thyroid cancer gender disparity","volume":"6","author":"Rahbari","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.738213","article-title":"Burden of Thyroid Cancer From 1990 to 2019 and Projections of Incidence and Mortality Until 2039 in China: Findings From Global Burden of Disease Study","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2025.103366_bib0007","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.arcmed.2025.103366_bib0008","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1158\/1078-0432.CCR-11-2892","article-title":"SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer","volume":"18","author":"Kim","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0009","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14740\/jocmr2480w","article-title":"Signaling Pathways in Thyroid Cancer and Their Therapeutic Implications","volume":"8","author":"Jin","year":"2016","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.arcmed.2025.103366_bib0011","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Cancer Genome Atlas Research N. Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2025.103366_bib0012","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2025.103366_bib0013","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2025.103366_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.arcmed.2025.103366_bib0015","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0016","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/2159-8290.CD-20-1230","article-title":"St. Jude Cloud: A Pediatric Cancer Genomic Data-Sharing Ecosystem","volume":"11","author":"McLeod","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.arcmed.2025.103366_bib0017","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0018","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0019","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1677\/ERC-07-0085","article-title":"New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy","volume":"14","author":"Riesco-Eizaguirre","year":"2007","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/erc.1.0978","article-title":"BRAF mutation in thyroid cancer","volume":"12","author":"Xing","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0021","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/PAI.0000000000000516","article-title":"BRAF V600E Mutation Across Multiple Tumor Types: Correlation Between DNA-based Sequencing and Mutation-specific Immunohistochemistry","volume":"26","author":"Loo","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0022","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.surg.2016.04.054","article-title":"Preoperative detection of RAS mutation may guide extent of thyroidectomy","volume":"161","author":"Patel","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.arcmed.2025.103366_bib0023","doi-asserted-by":"crossref","first-page":"E2031","DOI":"10.1210\/jc.2012-2092","article-title":"Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon","volume":"97","author":"Boichard","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2025.103366_bib0024","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/thy.2012.0207","article-title":"Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series","volume":"23","author":"Ciampi","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.arcmed.2025.103366_bib0025","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1210\/jc.2010-1921","article-title":"High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas","volume":"96","author":"Moura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2025.103366_bib0026","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40618-016-0526-5","article-title":"Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland","volume":"40","author":"Ciampi","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.arcmed.2025.103366_bib0027","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/mend-4-10-1474","article-title":"Point mutations of ras oncogenes are an early event in thyroid tumorigenesis","volume":"4","author":"Namba","year":"1990","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0028","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.3390\/cancers13153785","article-title":"Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer","volume":"13","author":"Marotta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2025.103366_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1440-1827.1995.tb03378.x","article-title":"N-ras mutation of thyroid tumor with special reference to the follicular type","volume":"45","author":"Oyama","year":"1995","journal-title":"Pathol Int"},{"key":"10.1016\/j.arcmed.2025.103366_bib0030","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1349-7006.1992.tb02722.x","article-title":"ras mutations in endocrine tumors: mutation detection by polymerase chain reaction-single strand conformation polymorphism","volume":"83","author":"Yoshimoto","year":"1992","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0031","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1200\/JCO.2003.10.130","article-title":"ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer","volume":"21","author":"Garcia-Rostan","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0032","first-page":"565","article-title":"Presence of mutations in all three ras genes in human thyroid tumors","volume":"5","author":"Suarez","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2025.103366_bib0033","first-page":"159","article-title":"High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis","volume":"4","author":"Lemoine","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2025.103366_bib0034","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.trecan.2015.07.004","article-title":"The Emerging Role of ABL Kinases in Solid Tumors","volume":"1","author":"Wang","year":"2015","journal-title":"Trends Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/ERC-19-0325","article-title":"Characterization of thyroid cancer driven by known and novel ALK fusions","volume":"26","author":"Panebianco","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0036","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.molcel.2022.04.034","article-title":"ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1","volume":"82","author":"Su","year":"2022","journal-title":"Mol Cell"},{"key":"10.1016\/j.arcmed.2025.103366_bib0037","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0463.2005.apm1130108.x","article-title":"Mutational analysis of the ARAF gene in human cancers","volume":"113","author":"Lee","year":"2005","journal-title":"APMIS"},{"key":"10.1016\/j.arcmed.2025.103366_bib0038","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/105072501300042802","article-title":"Analyses of MYC, ERBB2, and CCND1 genes in benign and malignant thyroid follicular cell tumors by real-time polymerase chain reaction","volume":"11","author":"Bieche","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.arcmed.2025.103366_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.109085","article-title":"Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks","volume":"715","author":"Gulfidan","year":"2022","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.arcmed.2025.103366_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1476-4598-13-105","article-title":"Targeting of erbB3 receptor to overcome resistance in cancer treatment","volume":"13","author":"Ma","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0041","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/pharmrev.121.000381","article-title":"The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein","volume":"74","author":"Lucas","year":"2022","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.arcmed.2025.103366_bib0042","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/431718","article-title":"EGF and TGF-beta1 Effects on Thyroid Function","volume":"2011","author":"Mincione","year":"2011","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0043","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1210\/en.2004-1134","article-title":"Fibroblast growth factor receptors as molecular targets in thyroid carcinoma","volume":"146","author":"St Bernard","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2025.103366_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072224","article-title":"Fibroblast growth factor receptor-2 expression in thyroid tumor progression: potential diagnostic application","volume":"8","author":"Redler","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2025.103366_bib0045","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.3390\/ijms20133258","article-title":"Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment","volume":"20","author":"Manzella","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2025.103366_bib0046","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1158\/1538-7445.AM2017-2137","article-title":"Abstract 2137: JAK2 as a novel therapeutic target in anaplastic thyroid cancer","volume":"77","author":"Pinto","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0047","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.18632\/oncotarget.26798","article-title":"MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer","volume":"10","author":"Garcia","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.arcmed.2025.103366_bib0048","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3390\/cancers13081932","article-title":"NTRK Fusion Genes in Thyroid Carcinomas: Clinicopathological Characteristics and Their Impacts on Prognosis","volume":"13","author":"Pekova","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2025.103366_bib0049","doi-asserted-by":"crossref","first-page":"R319","DOI":"10.1530\/ERC-19-0098","article-title":"Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer","volume":"26","author":"Zaballos","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0050","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1089\/thy.2016.0101","article-title":"ROS1 Rearrangement in Thyroid Cancer","volume":"26","author":"Ritterhouse","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.arcmed.2025.103366_bib0051","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.3390\/cancers13205184","article-title":"Molecular Signature Expands the Landscape of Driver Negative Thyroid Cancers","volume":"13","author":"Bim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2025.103366_bib0052","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0053","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1210\/jc.2007-1717","article-title":"Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population","volume":"93","author":"Abubaker","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2025.103366_bib0054","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-09-0727","article-title":"Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1","volume":"69","author":"Ricarte-Filho","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2025.103366_bib0056","doi-asserted-by":"crossref","DOI":"10.1210\/en.2006-0937","article-title":"AKT in thyroid tumorigenesis and progression","volume":"148","author":"Shinohara","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2025.103366_bib0057","first-page":"6105","article-title":"Overexpression and overactivation of Akt in thyroid carcinoma","volume":"61","author":"Ringel","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0058","first-page":"1177","article-title":"MicroRNA-338\u20133p inhibits thyroid cancer progression through targeting AKT3","volume":"7","author":"Sui","year":"2017","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0059","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1530\/JOE-17-0266","article-title":"Key signaling pathways in thyroid cancer","volume":"235","author":"Zaballos","year":"2017","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0060","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-06-1125","article-title":"Genetic alterations and their relationship in the phosphatidylinositol 3-kinase\/Akt pathway in thyroid cancer","volume":"13","author":"Hou","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0061","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.3390\/ijms19051448","article-title":"mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression","volume":"19","author":"Tavares","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2025.103366_bib0062","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1089\/thy.2010.1646","article-title":"Genetic alterations in the phosphatidylinositol-3 kinase\/Akt pathway in thyroid cancer","volume":"20","author":"Xing","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/j.arcmed.2025.103366_bib0063","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1007\/s11033-020-05435-1","article-title":"Role of PI3K\/AKT pathway in cancer: the framework of malignant behavior","volume":"47","author":"Jiang","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"D1","key":"10.1016\/j.arcmed.2025.103366_bib0064","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1093\/nar\/gkv1290","article-title":"Database resources of the National Center for Biotechnology Information","volume":"44","author":"Coordinators","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0065","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0066","article-title":"Prediction of Deleterious Non-synonymous SNPs of Human STK11 Gene by Combining Algorithms","volume":"9","author":"Islam","year":"2019","journal-title":"Molecular Docking, and Molecular Dynamics Simulation. Sci Rep"},{"key":"10.1016\/j.arcmed.2025.103366_bib0067","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/thy.2016.0254","article-title":"Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases","volume":"27","author":"Bonhomme","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/j.arcmed.2025.103366_bib0068","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.3747\/co.24.3555","article-title":"Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion-a case report","volume":"24","author":"Flader","year":"2017","journal-title":"Curr Oncol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0069","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1038\/sj.onc.1208615","article-title":"The p53 pathway: positive and negative feedback loops","volume":"24","author":"Harris","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2025.103366_bib0070","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s12020-013-0020-1","article-title":"Association of the ATM gene polymorphisms with papillary thyroid cancer","volume":"45","author":"Gu","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/j.arcmed.2025.103366_bib0071","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13053-022-00211-7","article-title":"CHEK2 mutations and papillary thyroid cancer: correlation or coincidence?","volume":"20","author":"Koen","year":"2022","journal-title":"Hered Cancer Clin Pract"},{"issue":"D1","key":"10.1016\/j.arcmed.2025.103366_bib0072","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0073","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/ijms18061325","article-title":"New Insights in Thyroid Cancer and p53 Family Proteins","volume":"18","author":"Manzella","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arcmed.2025.103366_bib0074","doi-asserted-by":"crossref","first-page":"E497","DOI":"10.1210\/jc.2013-1512","article-title":"Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas","volume":"99","author":"Pita","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2025.103366_bib0075","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3892\/mmr.2015.4731","article-title":"Analysis of somatic mutations in BRAF, CDKN2A\/p16 and PI3KCA in patients with medullary thyroid carcinoma","volume":"13","author":"Nascimento","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.arcmed.2025.103366_bib0076","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/org.4.2.5851","article-title":"Wnt signal transduction pathways","volume":"4","author":"Komiya","year":"2008","journal-title":"Organogenesis"},{"key":"10.1016\/j.arcmed.2025.103366_bib0077","first-page":"5576","article-title":"UCA1 promotes papillary thyroid carcinoma development by stimulating cell proliferation via Wnt pathway","volume":"22","author":"Lu","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.arcmed.2025.103366_bib0078","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.3892\/ol.2015.3578","article-title":"Germline and somatic mutations of the APC gene in papillary thyroid carcinoma associated with familial adenomatous polyposis: Analysis of three cases and a review of the literature","volume":"10","author":"Kumamoto","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.arcmed.2025.103366_bib0079","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0002-9440(10)64821-3","article-title":"Molecular evidence for multicentric development of thyroid carcinomas in patients with familial adenomatous polyposis","volume":"157","author":"Miyaki","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0080","first-page":"1317","article-title":"Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms","volume":"79","author":"Zeki","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2025.103366_bib0081","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2443.1998.00198.x","article-title":"Axin, an inhibitor of the Wnt signalling pathway, interacts with beta-catenin, GSK-3beta and APC and reduces the beta-catenin level","volume":"3","author":"Nakamura","year":"1998","journal-title":"Genes Cells"},{"key":"10.1016\/j.arcmed.2025.103366_bib0082","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/cancers11081162","article-title":"A Role for the WNT Co-Receptor LRP6 in Pathogenesis and Therapy of Epithelial Cancers","volume":"11","author":"Raisch","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2025.103366_bib0083","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1089\/thy.2004.14.1020","article-title":"Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers","volume":"14","author":"Kurihara","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.arcmed.2025.103366_bib0084","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10689-014-9775-7","article-title":"The roles of AXIN2 in tumorigenesis and epigenetic regulation","volume":"14","author":"Li","year":"2015","journal-title":"Fam Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0085","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.20960","article-title":"AXIN2 is Associated With Papillary Thyroid Carcinoma","volume":"18","author":"Liu","year":"2016","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.arcmed.2025.103366_bib0086","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0002-9440(10)64045-X","article-title":"Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis","volume":"158","author":"Garcia-Rostan","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0087","first-page":"1811","article-title":"Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma","volume":"59","author":"Garcia-Rostan","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0088","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12020-011-9558-y","article-title":"A rare S33C mutation of CTNNB1 encoding beta-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort","volume":"41","author":"Guarnieri","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.arcmed.2025.103366_bib0089","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3892\/or.2013.2557","article-title":"Key genes and pathways in thyroid cancer based on gene set enrichment analysis","volume":"30","author":"He","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.arcmed.2025.103366_bib0090","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1371\/journal.pmed.0040328","article-title":"An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT\/beta-catenin signaling","volume":"4","author":"Bjorklund","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.arcmed.2025.103366_bib0091","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23242","article-title":"TCF7L1 promotes skin tumorigenesis independently of beta-catenin through induction of LCN2","volume":"6","author":"Ku","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.arcmed.2025.103366_bib0092","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cmet.2011.02.014","article-title":"TLE3 is a dual-function transcriptional coregulator of adipogenesis","volume":"13","author":"Villanueva","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.arcmed.2025.103366_bib0093","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1007\/s13277-016-5250-4","article-title":"ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells","volume":"37","author":"Qiu","year":"2016","journal-title":"tumor Biol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0094","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-3-030-55031-8_10","article-title":"Notch Signaling in Thyroid Cancer","volume":"1287","author":"Guenter","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ymgme.2016.06.013","article-title":"CBP\/p300 acetyltransferase activity in hematologic malignancies","volume":"119","author":"Dutta","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.arcmed.2025.103366_bib0096","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1242\/jcs.114.13.2363","article-title":"p300\/CBP proteins: HATs for transcriptional bridges and scaffolds","volume":"114","author":"Chan","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.arcmed.2025.103366_bib0097","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10930-020-09951-8","article-title":"Update and Potential Opportunities in CBP Cyclic Adenosine Monophosphate (cAMP) Response Element-Binding Protein (CREB)-Binding Protein. Research Using Computational Techniques","volume":"40","author":"Akinsiku","year":"2021","journal-title":"Protein J"},{"key":"10.1016\/j.arcmed.2025.103366_bib0098","doi-asserted-by":"crossref","first-page":"25562","DOI":"10.1074\/jbc.M201196200","article-title":"Acetylation of beta-catenin by CREB-binding protein (CBP)","volume":"277","author":"Wolf","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2025.103366_bib0099","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","article-title":"The transcriptional coactivators p300 and CBP are histone acetyltransferases","volume":"87","author":"Ogryzko","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.arcmed.2025.103366_bib0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13045-021-01041-1","article-title":"The emerging role of KDM5A in human cancer","volume":"14","author":"Yang","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0101","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.1107474108","article-title":"Resistance to thyroid hormone is modulated in vivo by the nuclear receptor corepressor (NCOR1)","volume":"108","author":"Fozzatti","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2025.103366_bib0102","article-title":"Genetic Alterations in Papillary Thyroid Carcinoma With Hashimoto(')s Thyroiditis ANK3, an Indolent Maintainer of Papillary Thyroid Carcinoma","volume":"12","author":"Zeng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0103","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1530\/EC-19-0303","article-title":"Expression of NOTCH1 in thyroid cancer is mostly restricted to papillary carcinoma","volume":"8","author":"Piana","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.arcmed.2025.103366_bib0104","first-page":"837","article-title":"The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target","volume":"9","author":"Xiu","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0105","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.2147\/CMAR.S315511","article-title":"Targeting Notch4 in Cancer: Molecular Mechanisms and Therapeutic Perspectives","volume":"13","author":"Xiu","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.arcmed.2025.103366_bib0106","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fendo.2019.00510","article-title":"Keap1\/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer","volume":"10","author":"Renaud","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.arcmed.2025.103366_bib0107","first-page":"3125","article-title":"TGF-beta1 promotes the invasion and migration of papillary thyroid carcinoma cells by inhibiting the expression of lncRNA-NEF","volume":"17","author":"Xie","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.arcmed.2025.103366_bib0108","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/gim.2017.224","article-title":"The role of SMAD3 in the genetic predisposition to papillary thyroid carcinoma","volume":"20","author":"Wang","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2025.103366_bib0109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/ijmm.2021.4888","article-title":"Role and clinical significance of TGFbeta1 and TGFbetaR1 in malignant tumors (Review)","volume":"47","author":"Wang","year":"2021","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.arcmed.2025.103366_bib0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/(SICI)1097-0215(19990105)80:1<85::AID-IJC17>3.0.CO;2-P","article-title":"Overexpression of transforming growth factor beta-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells","volume":"80","author":"Turco","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0111","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005942","article-title":"Signaling pathways that regulate cell division","volume":"4","author":"Rhind","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0112","doi-asserted-by":"crossref","unstructured":"Vincent WY. Chapter 8 - The Cell Cycle 2018:197\u2013219.","DOI":"10.1016\/B978-0-12-809954-4.00008-6"},{"key":"10.1016\/j.arcmed.2025.103366_bib0113","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1097-0215(19960703)67:1<29::AID-IJC7>3.0.CO;2-1","article-title":"Status and expression of the p16INK4 gene in human thyroid tumors and thyroid-tumor cell lines","volume":"67","author":"Calabro","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0114","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.surg.2019.03.041","article-title":"Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma","volume":"167","author":"Maxwell","year":"2020","journal-title":"Surgery"},{"key":"10.1016\/j.arcmed.2025.103366_bib0115","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1530\/EJE-14-0461","article-title":"Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma","volume":"171","author":"Barbieri","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2017.02.064","article-title":"Genetics of medullary thyroid cancer: An overview","volume":"41","author":"Accardo","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.arcmed.2025.103366_bib0117","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/MCB.23.18.6542-6552.2003","article-title":"E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas","volume":"23","author":"Ziebold","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.arcmed.2025.103366_bib0118","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3390\/cancers14102461","article-title":"Looking at Thyroid Cancer from the Tumor-Suppressor Genes Point of View","volume":"14","author":"Rajabi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.arcmed.2025.103366_bib0119","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The Hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0120","first-page":"1320","article-title":"FAT1 somatic mutations in head and neck carcinoma are associated with tumor progression and survival","volume":"39","author":"Lin","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.arcmed.2025.103366_bib0121","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1677\/ERC-10-0205","article-title":"Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors","volume":"18","author":"Ory","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2025.103366_bib0122","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4149\/neo_2020_191224N1331","article-title":"Knockdown of microRNA-103a-3p inhibits the malignancy of thyroid cancer cells through Hippo signaling pathway by upregulating LATS1","volume":"67","author":"Zhang","year":"2020","journal-title":"Neoplasma"},{"key":"10.1016\/j.arcmed.2025.103366_bib0123","first-page":"21","article-title":"Analysis of Expression Profiles of GLI3A, LATS2 and MOB1A genes in Patients with Congenital hypothyroidism","volume":"3","author":"Eisazaei","year":"2022","journal-title":"J E"},{"key":"10.1016\/j.arcmed.2025.103366_bib0124","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3803\/EnM.2019.34.2.203","article-title":"Expression of NF2 Modulates the Progression of BRAF(V600E) Mutated Thyroid Cancer Cells","volume":"34","author":"You","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/j.arcmed.2025.103366_bib0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3390\/cells11040747","article-title":"Normal and Neoplastic Growth Suppression by the Extended Myc Network","volume":"11","author":"Prochownik","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.arcmed.2025.103366_bib0126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccell.2020.04.016","article-title":"MAX Functions as a Tumor Suppressor and Rewires Metabolism in Small Cell Lung Cancer","volume":"38","author":"Augert","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.arcmed.2025.103366_bib0127","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: a heritable breakup","volume":"72","author":"Cascon","year":"2012","journal-title":"Cancer Res"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440925001869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:22:16Z","timestamp":1780665736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440925001869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0188440925001869"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103366","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the Mutational Hierarchy of Thyroid Cancer and Associated Signaling Pathways","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2025.103366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103366"}}